Pembrolizumab Combination Therapy in Ovarian Cancer: Meta-Analysis Protocol

Systematic review and meta-analysis protocol examining efficacy and safety of pembrolizumab combination therapy in ovarian cancer

Publication Details

Journal
OSF Preprints (OSF Preprints)
Published
2025-01-01
DOI
https://doi.org/10.17605/osf.io/ycvsk
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pembrolizumab Combination Therapy in Ovarian Cancer: Meta-Analysis Protocol

OSF Preprints (OSF Preprints)
Cancer Immunotherapy and Biomarkers
article

Pembrolizumab Combination Therapy in Ovarian Cancer: Meta-Analysis Protocol

article en

Abstract

Systematic review and meta-analysis protocol examining efficacy and safety of pembrolizumab combination therapy in ovarian cancer

OSF Preprints (OSF Preprints)
Good health and well-being
Openalex Percentile: Top 39%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pembrolizumab Combination Therapy in Ovarian Cancer: Meta-Analysis Protocol · OSF Preprints (OSF Preprints) (2025) | TGRS Research Map | TGRS